Natural Alternatives International (NASDAQ:NAII) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a report published on Saturday. The firm issued a buy rating on the stock.

Natural Alternatives International Stock Up 1.2 %

NAII stock opened at $4.31 on Friday. The business’s fifty day moving average price is $4.40 and its two-hundred day moving average price is $5.26. The stock has a market capitalization of $26.72 million, a price-to-earnings ratio of -2.99 and a beta of 0.60. Natural Alternatives International has a fifty-two week low of $4.02 and a fifty-two week high of $7.26. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.56 and a quick ratio of 1.50.

Natural Alternatives International (NASDAQ:NAII) last issued its quarterly earnings data on Friday, September 27th. The company reported ($0.32) earnings per share for the quarter. The business had revenue of $29.49 million during the quarter. Natural Alternatives International had a negative return on equity of 10.23% and a negative net margin of 7.53%.

Institutional Trading of Natural Alternatives International

An institutional investor recently raised its position in Natural Alternatives International stock. Geode Capital Management LLC boosted its position in shares of Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 45,062 shares of the company’s stock after buying an additional 2,915 shares during the period. Geode Capital Management LLC owned approximately 0.73% of Natural Alternatives International worth $258,000 at the end of the most recent quarter. Institutional investors and hedge funds own 32.40% of the company’s stock.

About Natural Alternatives International

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.